Equifax Director and CEO Mark Begor Buys, Sells Shares in July 2025

Equifax Inc. (EFX) announces that Mark W Begor, Director and CEO, has executed a series of transactions on July 28, 2025. Begor purchased 27,960 shares at a price of $191.44 per share, while selling a total of 37,364 shares in multiple transactions at prices ranging from $244.95 to $241.87 per share. The transactions include the sale of 364 shares at $244.95 per share, 831 shares at $243.90 per share, 9,497 shares at $242.70 per share, 17,731 shares at $241.87 per share, and 19,841 shares at $240.95 per share.

Equifax Inc. (EFX) has announced that its CEO and Director, Mark W Begor, has executed a series of significant share transactions on July 28, 2025. According to a notice filed with the SEC, Begor purchased 27,960 shares at a price of $191.44 per share, while selling a total of 37,364 shares in multiple transactions at prices ranging from $244.95 to $241.87 per share.

The transactions include the sale of 364 shares at $244.95 per share, 831 shares at $243.90 per share, 9,497 shares at $242.70 per share, 17,731 shares at $241.87 per share, and 19,841 shares at $240.95 per share. The aggregate market value of the shares sold is approximately $118,507,42.56, while the number of shares outstanding is 123,797,380.

Begor's actions come amidst mixed market reactions to Equifax's second quarter results. The company reported revenue of $1.54 billion, a 7.4% year-on-year growth, and adjusted EPS of $2, beating analyst estimates [2]. However, the company faced challenges in its government and hiring-related business lines, with elevated litigation expenses and one-time costs tempering margin expansion.

Equifax's stock price has been volatile, trading at $240.89 as of July 2, 2025, down from $259.85 just before the earnings release. The company's market capitalization stands at $29.83 billion.

References:

[1] https://www.streetinsider.com/SEC+Filings/Form+144+EQUIFAX+INC+Filed+by%3A+Begor+Mark+W/25104803.html
[2] https://finance.yahoo.com/news/top-5-analyst-questions-equifax-053150416.html